StreetInsider.com News Articles

Emergent BioSolutions stock falls as CFO plans retirement

Fri, 16 Oct 2026 11:47:04 -0400

Investing.com -- Emergent Biosolutions Inc (NYSE:EBS) shares dropped 1292% Friday after the company announced that Chief Financial Officer Richard Lindahl will retire at the end of 2026.

Frank Vargo, vice president and treasurer, will assume the role of interim CFO effective January 1, 2027. Lindahl will serve as a senior executive advisor from January through March 2027 to support the transition.

Lindahl joined Emergent in 2018 and has served as CFO since that time. Prior to Emergent, he held CFO and senior finance roles at CEB and Sprint Nextel Corporation. He currently serves on the board of directors of

Emergent BioSolutions stock falls as CFO plans retirement

Fri, 16 Oct 2026 11:47:04 -0400

Investing.com -- Emergent Biosolutions Inc (NYSE:EBS) shares dropped 1292% Friday after the company announced that Chief Financial Officer Richard Lindahl will retire at the end of 2026.

Emergent BioSolutions CFO Richard Lindahl to retire end of 2026

Fri, 16 Oct 2026 07:50:15 -0400

Emergent BioSolutions Inc. (NYSE: EBS) announced that Richard S. Lindahl, executive vice president and chief financial officer, will retire from the company effective December 31, 2026.

Frank Vargo, currently vice president and treasurer, will take on the role of interim chief financial officer beginning January 1, 2027. Lindahl will remain with the company as a senior executive advisor through March 31, 2027 to support the transition.

Lindahl joined Emergent in 2018. Prior to that, he served as CFO of CEB, senior vice president and treasurer of Sprint Nextel Corporation, and vice president of finance at Pocket Communications, Inc. He also held positions

Emergent BioSolutions Announces Retirement of Chief Financial Officer Richard S. Lindahl

Fri, 16 Oct 2026 07:50:00 -0400

Appointment of Frank Vargo, VP, Treasurer, to Interim CFO effective January 1, 2027

GAITHERSBURG, Md.--(BUSINESS WIRE)-- Emergent BioSolutions Inc. (NYSE: EBS) today announced that Richard S. Lindahl, executive vice president, chief financial officer, will retire from the Company effective December 31, 2026. Frank Vargo, vice president, treasurer, will assume the role of interim chief financial officer effective January 1, 2027. To support a seamless transition, Rich will serve as a senior executive advisor from January 1 through March 31, 2027.

“On behalf of the Board of Directors and our colleagues, I want to thank Rich for his exceptional

Emergent BioSolutions Announces Retirement of Chief Financial Officer Richard S. Lindahl

Fri, 16 Oct 2026 07:50:00 -0400

Appointment of Frank Vargo, VP, Treasurer, to Interim CFO effective January 1, 2027

“On behalf of the Board of Directors and our colleagues, I want to thank Rich for his exceptional

Form 8-K Emergent BioSolutions For: Oct 16

Fri, 16 Oct 2026 07:48:00 -0400

si-local-file:///var/storage/secattach/20261016/27195760.html

Emergent BioSolutions to Report Third Quarter 2026 Financial Results on November 2, 2026

Thu, 15 Oct 2026 08:00:00 -0400

GAITHERSBURG, Md.--(BUSINESS WIRE)-- Emergent BioSolutions Inc. (NYSE: EBS) will host a conference call on Monday, November 2, 2026, at 5:00 p.m. eastern time to discuss the financial results for the third quarter of 2026.

Participants can access the conference call via webcast and also by visiting the Investors page of Emergent’s website. Participants can pre-register for the teleconference at the following link and will receive an email with a calendar reminder, dial-in number and a unique code that allows immediate access to the call.

To join by

Emergent BioSolutions to Report Third Quarter 2026 Financial Results on November 2, 2026

Thu, 15 Oct 2026 08:00:00 -0400

To join by

Form 144 Emergent BioSolutions Filed by: DeGolyer Donald W

Wed, 07 Oct 2026 16:04:00 -0400

si-local-file:///var/storage/secattach/20261007/27161193.html

Form 4 Emergent BioSolutions For: Oct 07 Filed by: DeGolyer Donald W

Wed, 07 Oct 2026 15:45:00 -0400

si-local-file:///var/storage/secattach/20261007/27161091.html

US Escalates Pressure On Russia Over Siberia Lab Death - WSJ

Tue, 06 Oct 2026 15:56:16 -0400

US Escalates Pressure On Russia Over Siberia Lab Death - WSJ

WSJ Cites Us Officials On Warning To Russia
US Officially Asked Russia For More Information On Plague

Trump On Plague: Looking At It Very Strongly - Bloomberg

Mon, 05 Oct 2026 15:29:21 -0400

Trump On Plague: Looking At It Very Strongly

Trump On Russia, Plague: We'll Help Them
Trump On Russia, Plague: We Just Heard About It

Trump On Plague: Looking At It Very Strongly - Bloomberg

Mon, 05 Oct 2026 15:29:21 -0400

Trump On Plague: Looking At It Very Strongly

Trump On Russia, Plague: We'll Help Them
Trump On Russia, Plague: We Just Heard About It

Rubio urges calm as U.S. tracks suspected pneumonic plague death at Russian lab

Mon, 05 Oct 2026 10:33:16 -0400

Investing.com -- U.S. Secretary of State Marco Rubio and the State Department are closely monitoring a suspected pneumonic plague outbreak in Siberia following the death of a Russian laboratory researcher, balancing calls for Moscow’s transparency with measured reassurances to the public.

Speaking to reporters Monday before departing for a diplomatic trip to Europe, Secretary Rubio addressed the fatal incident at the Irkutsk Anti-Plague Research Institute. "We’re watching and monitoring it closely," Rubio stated. "I don’t think it’s cause for alarm". The State Department backed his remarks with a formal statement confirming coordination with the Centers for Disease

Rubio urges calm as U.S. tracks suspected pneumonic plague death at Russian lab

Mon, 05 Oct 2026 10:33:16 -0400

Rubio urges calm as U.S. tracks suspected pneumonic plague death at Russian lab

Mon, 05 Oct 2026 10:33:16 -0400

Rubio urges calm as U.S. tracks suspected pneumonic plague death at Russian lab

Mon, 05 Oct 2026 10:33:16 -0400

Form 4 Emergent BioSolutions For: Oct 01 Filed by: Williams Paul Anthony

Mon, 05 Oct 2026 09:16:00 -0400

si-local-file:///var/storage/secattach/20261005/27146732.html

Form 144 Emergent BioSolutions Filed by: Williams Paul Anthony

Thu, 01 Oct 2026 16:20:00 -0400

si-local-file:///var/storage/secattach/20261001/27136263.html

Media Advisory: Emergent to Host Ribbon Cutting Ceremony at Canton Manufacturing Facility

Tue, 15 Sep 2026 07:45:00 -0400

Company leaders, elected officials and community stakeholders will come together on September 16, 2026 to mark milestone in advanced biopharmaceutical manufacturing

CANTON, Mass., Sept. 15, 2026 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) will host a ribbon cutting ceremony on Wednesday, September 16 at 10 a.m. ET to celebrate the manufacturing restart and growth of its Canton, Massachusetts facility and the company’s investment in the future of advanced biopharmaceutical manufacturing in the Commonwealth.

The event will highlight Emergent's commitment to strengthening domestic manufacturing capabilities, supporting public health preparedness and creating opportunities for skilled jobs in Massachusetts.

Media Advisory: Emergent to Host Ribbon Cutting Ceremony at Canton Manufacturing Facility

Tue, 15 Sep 2026 07:45:00 -0400

Company leaders, elected officials and community stakeholders will come together on September 16, 2026 to mark milestone in advanced biopharmaceutical manufacturing

Form 8-K Emergent BioSolutions For: Sep 14

Mon, 14 Sep 2026 16:02:00 -0400

si-local-file:///var/storage/secattach/20260914/27058312.html

Emergent BioSolutions buys back $75M in senior unsecured notes

Thu, 03 Sep 2026 07:45:34 -0400

Emergent BioSolutions Inc. (NYSE: EBS) has completed the repurchase of $75 million aggregate principal amount of its 3.875% Senior Unsecured Notes due 2028, according to a company statement.

The Gaithersburg, Md.-based company deployed approximately $68 million in cash for the repurchases, at an average price of 90.6% of face value. Following the transactions, the outstanding aggregate principal balance of the Senior Unsecured Notes has been reduced to approximately $364.7 million.

The repurchases were authorized by Emergent's Board of Directors. The company said it plans to monitor market conditions and evaluate the timing for refinancing the remaining outstanding notes, which mature in August

Emergent BioSolutions Completes Repurchase of $75 Million Aggregate Principal Amount of Senior Unsecured Notes

Thu, 03 Sep 2026 07:45:00 -0400

Repurchase reduces unsecured note balance to approximately $364.7 million
Management to discuss this key milestone and broader transformation progress at upcoming investor conferences

GAITHERSBURG, Md., Sept. 03, 2026 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced that it has completed the repurchase of $75 million aggregate principal amount of its 3.875% Senior Unsecured Notes due 2028 (the “Senior Unsecured Notes”), following authorization granted by its Board of Directors. In total, Emergent deployed approximately $68 million of cash for the repurchases, resulting in an average repurchase price of 90.6% of

Emergent BioSolutions Completes Repurchase of $75 Million Aggregate Principal Amount of Senior Unsecured Notes

Thu, 03 Sep 2026 07:45:00 -0400

Repurchase reduces unsecured note balance to approximately $364.7 million
Management to discuss this key milestone and broader transformation progress at upcoming investor conferences